Article
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
10 Nov 2021
Abstract excerpt
Metabolites, the biochemical products of the cellular process, can be used to measure alterations in biochemical pathways related to the pathogenesis of Alzheimer's disease (AD). However, the relationships between systemic abnormalities in metabolism and the pathogenesis of AD are poorly understood. In this study, we aim to identify AD-specific metabolomic changes and their potential upstream genetic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
